Nima Naderi Selected Research

Formaldehyde (Formol)

1/2021	High-performance thin-layer chromatography fingerprinting and anti-inflammatory and antinociceptive activities of Pyracantha coccinea M.Roem.: A laboratory-based study.
1/2013	Evaluation of Anti-nociceptive and Anti-inflammatory Activities of Novel Chalcone Derivatives.
4/2012	The interaction between intrathecal administration of low doses of palmitoylethanolamide and AM251 in formalin-induced pain related behavior and spinal cord IL1-β expression in rats.
1/2010	Formalin-induced differential activation of nucleus cuneiformis neurons in the rat: an electrophysiological study.
5/2005	Interaction between gamma-aminobutyric acid GABAB and cannabinoid CB1 receptors in spinal pain pathways in rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nima Naderi Research Topics

Disease

8	Epilepsy (Aura) 05/2022 - 11/2008
5	Pain (Aches) 01/2021 - 05/2005
5	Infarction (Infarctions) 12/2020 - 01/2017
4	Seizures (Absence Seizure) 01/2019 - 07/2013
3	Edema (Dropsy) 01/2021 - 08/2007
3	Ischemia 12/2020 - 01/2018
3	Cognitive Dysfunction 01/2019 - 01/2018
3	Neoplasms (Cancer) 01/2019 - 01/2013
2	Stroke (Strokes) 04/2019 - 01/2017
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2019 - 01/2017
2	Temporal Lobe Epilepsy 01/2019 - 04/2016
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 01/2013
2	Neuroinflammatory Diseases 01/2019 - 01/2017
2	Multiple Sclerosis 01/2016 - 01/2015
2	Alzheimer Disease (Alzheimer's Disease) 01/2015 - 01/2013
2	Asthma (Bronchial Asthma) 08/2013 - 01/2013
1	Rabies (Hydrophobia) 07/2022
1	Atherosclerosis 04/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2021
1	Nervous System Diseases (Neurological Disorders) 12/2020
1	Cerebral Infarction 04/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2017
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2016
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2015
1	Demyelinating Diseases (Demyelinating Disease) 06/2013

Drug/Important Bio-Agent (IBA)

5	Formaldehyde (Formol)FDA Link 01/2021 - 05/2005
4	CannabinoidsIBA 04/2012 - 05/2005
3	Anticonvulsants (Antiepileptic Drugs)IBA 05/2022 - 02/2012
3	Pilocarpine (Ocusert)FDA LinkGeneric 01/2019 - 01/2015
3	salicylhydroxamic acid (SHAM)IBA 01/2019 - 01/2018
2	CarrageenanIBA 01/2021 - 08/2007
2	Atorvastatin (Lipitor)FDA Link 04/2019 - 01/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2019 - 01/2017
2	Galectin 3 (LGALS3)IBA 01/2019 - 01/2013
2	citrus pectinIBA 01/2019 - 01/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 01/2013
2	CytokinesIBA 01/2019 - 01/2018
2	Neuroprotective AgentsIBA 01/2019 - 01/2018
2	CannabidiolIBA 04/2016 - 07/2013
2	palmidrolIBA 11/2015 - 04/2012
2	Codon (Codons)IBA 08/2013 - 01/2013
1	Glycoproteins (Glycoprotein)IBA 07/2022
1	anandamide (arachidonylethanolamide)IBA 05/2022
1	Pentylenetetrazole (Metrazol)IBA 11/2021
1	Acrolein (Aqualin)IBA 04/2021
1	ethyl acetateIBA 01/2021
1	Chloroform (Trichloromethane)IBA 01/2021
1	aniline (aniline hydrobromide)IBA 12/2020
1	pluronic-chitosanIBA 12/2020
1	HydrogelsIBA 12/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2020
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 12/2020
1	Malondialdehyde (Propanedial)IBA 04/2019
1	fluoro jadeIBA 04/2019
1	coenzyme Q10 (CoQ10)IBA 04/2019
1	8-Hydroxy-2'-DeoxyguanosineIBA 04/2019
1	benzimidazoleIBA 01/2019
1	tyrosine receptor (receptor, tyrosine)IBA 01/2019
1	CrizotinibIBA 01/2019
1	Toll-Like Receptor AgonistsIBA 01/2019
1	BenzoxazolesIBA 01/2019
1	ChloridesIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	Naltrexone (ReVia)FDA LinkGeneric 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Cell Surface ReceptorsIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	IntegrinsIBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	Lipid AIBA 01/2018
1	monophosphoryl lipid AIBA 01/2018
1	phthalimideIBA 01/2018
1	Saline SolutionIBA 01/2018
1	PotassiumIBA 01/2017
1	CalciumIBA 01/2017
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 04/2016
1	AntioxidantsIBA 04/2016
1	MercuryIBA 01/2016
1	iodopravadoline (AM 630)IBA 11/2015
1	Potassium Channels (Potassium Channel)IBA 01/2015
1	Ion Channels (Ion Channel)IBA 01/2015
1	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2013
1	Fluticasone (Cutivate)FDA LinkGeneric 08/2013
1	Salmeterol Xinafoate (Serevent)FDA Link 08/2013
1	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 08/2013
1	arginylarginine (Arg-Arg)IBA 08/2013
1	paxillineIBA 07/2013
1	Luxol Fast Blue MBS (Luxol fast blue)IBA 06/2013

Therapy/Procedure

2	Therapeutics 01/2015 - 01/2013
1	Deep Brain Stimulation 12/2021
1	Injections 12/2020
1	Secondary Prevention 04/2019
1	Intraperitoneal Injections 01/2019
1	Aftercare (After-Treatment) 04/2016